SEROPREVALENCE OF CHICKUNGUNYA IN A TERTIARY CARE HOSPITAL
DOI:
https://doi.org/10.22159/ijcpr.2024v16i5.5061Keywords:
Chickungunya, Aedes aegypti, Aedes albopictus, High fever, IgM ELISAAbstract
Objective: Chickungunya is a mosquito borne, arboviral disease, causing abrupt onset of fever and severe arthralgia. It is transmitted by vector Aedes aegypti and Aedes albopictus. It has been an increasingly important health threat. The aim of the present study was to estimate the seroprevalence and magnitude of chickungunya in febrile cases in a tertiary care hospital Visakhapatnam.
Methods: A prospective study was conducted for a period of 2 y, from January 2022 to December 2023 from cases admitted for high fever, maculopapular rash, and severe joint pains. A total of 1044 blood samples were received for testing of chikunugunya IgM antibodies by ELISA in the Virology Laboratory, Department of Microbiology.
Results: 11.2% were seropositive for chikungunya IgM. Most affected gender and age group in the study were female [59%] and 26 to 30 y [30.1%]. Maximum cases in this study were recorded in the months of June 2022 [33.3%] and July 2023 [22.4%].
Conclusion: Continuous monitoring of fever cases will allow detection of chickungunya fever outbreaks and enables to establish effective preventive measures. Since there is no definitive treatment available, identifying ways to abolish mosquito population would be the most useful strategy to control the disease.
Downloads
References
Robinson MC. An epidemic of virus disease in southern province tanganyika territory in 1952-53. I. Clinical features. Trans R Soc Trop Med Hyg. 1955;49(1):28-32. doi: 10.1016/0035-9203(55)90080-8, PMID 14373834.
Rolph MS, Foo SS, Mahalingam S. Emergent chikungunya virus and arthritis in the americas. Lancet Infect Dis. 2015;15(9):1007-8. doi: 10.1016/S1473-3099(15)00231-5, PMID 26333330.
Adam A, Jassoy C. Epidemiology and laboratory diagnostics of dengue yellow fever zika and chikungunya virus infections in Africa. Pathogens. 2021;10(10)324. doi: 10.3390/pathogens10101324, PMID 34684274.
Mwongula AW, Mwambwi LA, Matilu M. Seroprevalence of chickungunya infection in pyretic children seeking treatment in Alupr District Hospital Busia County Kenya. Int J Curr Microbiol Appl Sci. 2013;2(5):130-9.
Chik IN. IgM capture ELISA kit. Version 3.4; 2013.
Mansfield KL, Horton DL, Johnson N, Li L, Barrett AD, Smith DJ. Flavivirus-induced antibody cross reactivity. J Gen Virol. 2011;92(12):2821-9. doi: 10.1099/vir.0.031641-0, PMID 21900425.
NVBDCP. In: NO F. editor 1; 2009. p. Z-17013. Available from: http://ncvbdc.mohfw.gov.
Medhekar P, Hirani N, Ingale H, Chowdhary A. Seroprevalence of chickungunya infection in a Tertiary Care Hospital in Mumbai. Indian J Appl Res. 2018 Sep;8(9):8-9. doi: 10.36106/ijar.
Parashar D, Patil D. Chickungunya: a disease re-emerged in India after 32 y publication of NIV commemorative compendium; 2012. p. 221-42.
Kumar K, Chhabra M, Katyal R, Patnaik PK, Kukreti H, Rai A. Investigation of an outbreak of chikungunya in Malegaon Municipal areas of Nasik District Maharashtra (India) and its control. J Vector Borne Dis. 2008 Jun;45(2):157-63. PMID 18592845.
Chikkaraddi U, S MK, R SN, AD. Seroprevalence of chikungunya fever in a Tertiary Care Hospital in North Karnataka. IJMMTD. 2020;4(4):240-2. doi: 10.18231/2581-4761.2018.0052.
Wasti H, Farman S, Naseeb U. Chickungunya fever commentary. JBUMDC. 2017; 7(2):125-7.
Published
How to Cite
Issue
Section
Copyright (c) 2024 THAMMINA MEHER SRI SAI SUDHA VANI, MATTAM SUNEETHA RANI, JYOTHI PENDYALA, ASHOK KUMAR VINNAKOTI
This work is licensed under a Creative Commons Attribution 4.0 International License.
